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Abstract
Background: Overwhelmed, under-trained medical staff working in resource-limited settings 
need efficient resources for HIV disclosure counselling. The objective of this study was to describe 
providers’ experiences using tablet computers for disclosure-related counselling with HIV-infected 
children and their caregivers in western Kenya, with additional perspectives from adolescents.
Methods: A qualitative study design was implemented at three HIV clinics in western Kenya 
(Bumala, Busia, and Port Victoria) within Academic Model Providing Access to Healthcare 
(AMPATH). Twenty-one healthcare providers involved with pediatric disclosure were recruited 
and enrolled in the study. Initial interviews focused on understanding current disclosure practices 
and barriers. Tablets containing disclosure-related resources were distributed. Resources included 
short narrative videos created in this context to highlight issues relevant to child HIV disclosure.
Results: Providers reported tablets improved disclosure, child participation, and medication 
adherence. All reported that reviewing materials increased their knowledge and comfort with 
disclosure. The most frequently used materials were the narrative videos and an animated video 
explaining the importance of medication adherence. Time was a major barrier for using the tablet. 
Clinician self-education persisted at one-year follow-up. Adolescents expressed enjoyment from 
viewing the tablet resources and had a better understanding of the importance of medication 
adherence.
Conclusions: Tablet computers containing resources for disclosure are an acceptable and 
potentially effective resource to help providers support families with disclosure. Further work is 
needed to appropriately train the clinical providers in using the resources in a developmentally 
appropriate manner, as well as to develop new resources on adolescent-specific and HIV-related 
topics.
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Introduction
More than two million adolescents are HIV-infected, with approximately 90% living in sub-
Saharan Africa (World Health Organization, 2014). While most have been HIV-infected 
since birth, many do not know their own HIV status (Vreeman, Gramelspacher, Gisore, 
Scanlon, & Nyandiko, 2013). Timely disclosure of HIV status is critical for adolescents’ 
long-term disease management and transitions into adult care (Vreeman et al., 2013). Best 
practices for HIV disclosure are not well characterized. However, current recommendations 
for HIV disclosure include providing gradual, individualized, age-appropriate information 
about HIV and counselling services for both the child and the caregiver (New York State 
Department of Health, 2009).
HIV stigma and discrimination make HIV disclosure a challenge worldwide. However, these 
challenges are exacerbated in resource-limited settings (RLS) due to insufficient numbers of 
healthcare providers and limited training in HIV disclosure and counselling. The World 
Health Organization (WHO) reports an average of 2.5 physicians/10 000 people in low-
income countries, which is only 1/10 of the rate in the United States (World Health 
Organization, 2015). Moreover, populations in African countries bear over 24% of the global 
burden of disease yet only have access to 3% of the world’s healthcare workers (AVERT, 
2014; World Health Organization, 2015). Overwhelmed, undertrained medical staff working 
in RLS frequently have little-to-no knowledge of appropriate methods of HIV disclosure and 
limited culturally appropriate resources to help support caregivers during the process of HIV 
disclosure to adolescents (Beima-Sofie et al., 2014; Rujumba, Mbasaalaki-Mwaka, & 
Ndeezi, 2010; Vaz, Eng, Maman, Tshikandu, & Behets, 2010).
In such settings, cost-effective and practical methods of education and patient counselling 
are necessary to help alleviate this health gap (Ajay & Prabhakaran, 2011; Nicholas, 2008). 
The use of small electronic devices, such as tablet computers, is a potential avenue to 
provide healthcare education to this critically underserved population. These devices are also 
financially feasible and do not add greater burdens on the overstretched healthcare 
workforce (Aviles, Ortega, Kuan, Coloma, & Harris, 2008; Catalani, Philbrick, Fraser, 
Mechael, & Israelski, 2013; Clifford & Clifton, 2012; Folaranmi, 2014; Labrique, 
Vasudevan, Kochi, Fabricant, & Mehl, 2013). Portable electronic devices have proven to be 
beneficial in providing health education to medical providers and improving healthcare 
knowledge and clinical outcomes in both resource-rich and resource-limited settings 
(Finkelstein et al., 2012; Ventola, 2014). For RLS, tablet computers are a particularly well-
suited resource, due to their low demands for electricity and functionality not requiring 
internet connectivity (Catalani et al., 2013; Dowshen, Kuhns, Johnson, Holoyda, & 
Garofalo, 2012; Finkelstein et al., 2012; Mackenzie et al., 2007). Despite these benefits, a 
recent systematic review revealed that this technology has not been frequently utilized in 
RLS (McHenry, Fischer, Chun, & Vreeman, 2017). Possible reasons for this underutilization 
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may include unfamiliarity with the technology, availability, and concerns about theft and the 
necessity of internet connections (Lazarus, Sookrajh, & Satyapal, 2017; Witt et al., 2016; 
Zolfo et al., 2010). In Kenya, where this study takes place, most adolescents do not have 
access to tablets or computers in their own homes, which limits their widespread use (Pew 
Research Center, 2016). However, HIV-infected children and adolescents are expected to 
follow-up regularly at HIV clinics, which provides an opportunity to interact with tablet 
computers at clinic. Using these technologies may support clinical providers, caregivers, and 
adolescents during the challenging process of HIV disclosure.
The objective of this study was to evaluate clinical providers’ perceptions and experiences of 
using tablet computers loaded with multimedia resources for disclosure-related counselling 
with HIV-infected adolescents and their caregivers at several HIV clinics in western Kenya. 
Additionally, we solicited perspectives from adolescents attending those clinics regarding 
their experiences with the tablets. We hypothesized that clinical providers would perceive 
tablet computers as an acceptable resource for HIV disclosure and using the tablet would 
improve the HIV disclosure process in their clinics.
Methods
Study Design and Participants
This study used a longitudinal, mixed methods research design, with interviews, 
questionnaires, and surveys with clinical providers at three clinics in western Kenya. The 
study team contacted the clinic managers at each study site to identify clinical providers that 
were involved in adolescent disclosure to target for recruitment. The clinic managers were 
each allowed to identify up to 7 eligible clinical providers, by limited the number of tablets 
available for use. From this convenience sample, all identified clinical providers were 
recruited by a research assistant. The research assistant reviewed information about the study 
in both verbal and written form, and written consent was obtained from each participant. 
This process occurred within one month of contacting the clinic managers. The clinical 
providers included clinical officers, nurses, and social support staff. Clinical officers are 
non-specialized, mid-level providers, similar to a nurse practitioner or physician’s assistant, 
who provide the majority of medical care in these clinics. Inclusion criteria for the clinical 
providers included: working with HIV-infected adolescents and their caregivers during the 
disclosure process and working at one of the three study site clinics.
During the one-year follow-up, HIV-infected, disclosed adolescents at each clinic were 
recruited for a one-time interview regarding tablet implementation in their clinics. In this 
study, an adolescent was defined as an individual between the ages of 10–19 years (World 
Health Organization, 2017). Inclusion criteria for the adolescents included: being HIV-
infected, between 10 and 19 years of age; knowing their own HIV status; and receiving care 
at one of the three study site clinics. Convenience sampling was performed by the clinical 
providers who were caring for adolescents at that clinic. This was performed during a one-
month period when clinical providers asked adolescents coming into clinic if they would be 
interested in participating in a study. If they expressed interest, the clinical provider provided 
their contact information to the research team. A research assistant then contacted the family 
to review the study information sheet verbally with the adolescent and their caregiver. 
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Written consent and assent were obtained from both the caregiver and adolescents, 
respectively. In cases where the adolescent was 18 years or older, only written participant 
consent was required. A minimum of 5 adolescent participants per clinic site were targeted 
for recruitment, as fewer participants may negatively impact the group dynamics required to 
elicit collective viewpoints (Carlsen & Glenton, 2011). Only one focus group was performed 
at each clinic due to logistic considerations.
Setting:
This study took place from July 2015 - June 2016 at three rural HIV clinics in western 
Kenya within Academic Model Providing Access to Healthcare (AMPATH). Born from a 
20-year partnership between Indiana University School of Medicine, Moi University School 
of Medicine, and the Moi Teaching and Referral Hospital in Eldoret, Kenya, AMPATH 
currently treats over 130 000 adult and pediatric patients with funding from the Presidential 
Emergency Plan for AIDS Relief at 25 clinics and 40 satellite clinics in western Kenya 
(Einterz et al., 2007; Inui et al., 2007). AMPATH provides care to over 25 000 HIV-infected 
and HIV-exposed children, including approximately 6 000 children under the age of 15 years 
on anti-retroviral therapy.
Non-specialized, non-physician providers (i.e. clinical officers) primarily staffed the clinics 
included in this study. Prior to initiation of this study, AMPATH had a Standard Operating 
Procedure (SOP) in place for its clinics outlining a protocol for HIV disclosure practices in 
which HIV disclosure was supposed to begin by age 10 years. At the conclusion of this 
study, Study Site 1 had over 6 000 individuals actively in care, Study Site 2 had nearly 3 000 
individuals actively in care, and Study Site 3 had approximately 700 individuals actively in 
care (AMPATH, 2016). Within each clinic, approximately 10% of its population was under 
the age of 15 years (AMPATH, 2016).
Tablet resources:
Android tablets were donated to AMPATH by a large technology company in 2014. These 
were loaded with materials developed as part of an ongoing HADITHI disclosure 
intervention trial (PIs: Nyandiko and Vreeman). Resources on tablets included: general HIV 
treatment guidelines (Kenya Ministry of Health, 2014), AMPATH Standard Operating 
Procedures, general educational materials on HIV and disclosure, counselling-based 
activities to use with caregivers and adolescents, New York guidelines for HIV disclosure for 
adolescents (New York State Department of Health, 2009), pamphlets developed locally for 
general and HIV-specific adolescent care issues such as relationships and dealing with stress, 
Living Positively Workbook (Children’s Rights Centre), children’s books about HIV, a 
locally developed, culturally appropriate animation explaining HIV and the importance of 
medication adherence (Fischer et al., 2015), and eight culturally appropriate video narratives 
sharing family members’ and adolescents’ experiences of HIV and disclosure (McAteer et 
al., 2016) (Materials used in this study and HADITHI are available at: http://indiana.edu/
~hadithi). The study team members who created and provided the curated tablets were not 
involved in study procedures to avoid unintentional influence.
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Ethical considerations:
An ethical consideration that arose during study planning was the possibility of accident 
disclosure. Accidental disclosure occurs when an individual unintentionally learns of their 
HIV status without the appropriate psychosocial support. The resources within the tablet 
were organized to minimize the likelihood of accidental disclosure occurring. Folders on the 
tablets were used to distinguish materials appropriate for use in pre-disclosed vs. disclosed 
adolescents, as well as materials available in English or Kiswahili. Participants were shown 
how to operate the tablets and access the resources for both disclosed and non-disclosed 
adolescents during distribution. They were instructed to review the materials on the tablets 
before using them with adolescents. No further instructions on the use of the materials were 
given, to facilitate use of the tablets at the participants’ own discretion.
This study was approved by the Institutional Review Board of Indiana University School of 
Medicine in Indianapolis, Indiana, United States of America and by the Institutional 
Research and Ethics Committee of Moi University School of Medicine and Moi Teaching 
and Referral Hospital in Eldoret, Kenya.
Data collection methods:
In order to achieve our objective to evaluate providers’ perceptions and experiences of using 
tablet computers for disclosure-related counselling, multiple methods of data collection were 
utilized, including questionnaires, surveys, and semi-structured interviews. Prior to 
distributing the tablets, exploratory semi-structured interviews were performed with clinical 
providers at each clinic to understand the current disclosure environment in their clinics. 
After distribution of the tablets to participants, data regarding use of the tablets over the 
prior week were collected via monthly surveys over a 5-month period. The survey questions 
focused on the following: clinical patient volume; frequency of tablet use (e.g. ‘Over the last 
week, how often have you used the tablets?’ with categorical answer options including 
never, 25%, 50%, 75%, nearly all interactions); materials regularly used with patients on the 
tablets, time spent using the tablet, populations with whom the tablet is used (with 
categorical options such as non-disclosed adolescents, disclosed adolescents, caregivers, 
other clinical staff, as well as a free text option); methods of using the tablet (with 
categorical options such as giving the table to a client to look through while completing 
paperwork, showing clients the video then ask questions after the video is completed, 
watching the video with frequent pauses to discuss what is being viewed, as well as a free 
text option); adolescents’ reaction to the tablet (with options including: confused, sad, angry, 
quiet, excited, joyful, as well as a free text option); and materials reviewed by the clinical 
provider on their own time. Free text space was available at the end of each survey for 
participants to describe their experiences with the tablets. The complete survey is available 
upon request. Paper surveys were identifiable only by study ID number and were returned to 
the study coordinators each month. After the 5-month period, repeat semi-structured 
interviews were performed to understand participants’ experiences with the tablets.
One year after implementation of the tablet computers, a follow-up survey was administered 
to the clinical providers, and the adolescents were recruited for interviews. For all interviews 
performed within this study, participants were asked their preference in speaking in either 
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English or Kiswahili (Kenya’s two national languages), and the interview took place in their 
preferred language. Interview recordings were transcribed and translated (if needed) by 
research staff fluent in English and Kiswahili for analysis.
Data analysis:
Qualitative data: All interview transcripts were analyzed to arrive at a contextualized 
understanding of the clinical providers’ experiences using the tablets for HIV disclosure 
process with adolescents and their caregivers. For the baseline interviews, a priori codes 
were created prior to data analysis. These codes emanated from the interview guide and 
were used as a starting point for analysis. We then employed constant comparison, axial 
coding, and triangulation to identify central concepts (Glaser & Strauss, 1967; Strauss & 
Corbin, 1990). The initial stage of constant comparative analysis was done through coding 
by investigators (M.S.M, L.J.F, C.I.M, J.A., R.O.A). Line-by-line coding was individually 
performed by the investigators (M.S.M, C.I.M) using the qualitative analysis software 
Dedoose – a web application for managing, analyzing, and presenting qualitative and mixed 
method research data (“Dedoose Web Application for Managing, Analyzing, and Presenting 
Qualitative and Mixed Methods Research Data,” 2014). Relevant themes and concepts were 
developed inductively from these data. Data collected from the follow-up participant 
interviews and adolescent groups were the result of targeted questioning. Triangulation was 
used with these to evaluate validity of monthly survey data and the overall experience of 
clinical providers using the tablets for disclosure. Similar methods were used for analyzing 
the transcripts from the adolescent interviews. Quotes, edited minimally for clarity, are 
provided in the text to add descriptive detail and highlight major themes.
Quantitative Data—Fisher’s Exact Test was used to evaluate differences between 
categorical demographic variables within the participants. We analyzed the Likert scale 
scores using standard summary statistics: mean, median, and standard deviation for the 
ordinal variables. Wilcoxon signed ranks test was used to evaluate differences of the ordinal 
data from the Likert scales between differing time points in survey administration. Kruskal-
Wallis was used to see if there was a difference between clinics, gender, or clinical position, 
each as independent groups, for the ordinal variables of comfort, ability, knowledge, impact 
of tablet, and patient’s reaction to the tablet, individually. Level of significance (α) was set 
at 0.05. Analyses were performed using procedures appropriate for survey data in SAS 
Version 9.4.
Results
Study Participants’ Characteristics:
With the support of the in-charge clinical officer at each clinic, all healthcare providers 
involved in the disclosure process were identified and recruited for this study. All recruited 
providers (n=21) agreed to participate in this study. Overall, 62% (13/21) were female and 
38% (8/21) were clinical officers with the remainder trained as nurses or in social support 
roles (Table 1). No significant differences between participant demographics was noted 
between clinics.
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Baseline Interviews:
Participants overwhelmingly believed that it was the adolescent’s primary caregiver’s 
responsibility to direct the disclosure process, although they often reported having to initiate 
the disclosure with the adolescents because of the caregiver’s reluctance. They believed the 
healthcare workers’ roles should be to support the caregivers in disclosure, answer questions 
from the adolescents regarding HIV and treatment, and identify the disclosure status of the 
adolescents to tailor their visits appropriately. One clinician noted:
“[Caregivers] are the ones who need to be armed with information to support the 
child when they ask questions or maybe when depressed at home; they are there for 
them. Maybe the child will see us once in a month and so what happens to the other 
27 days while he/she is not with us?”
Many described situations when they had to initiate disclosure when caregivers had not. 
Providers described being compelled to initiate disclosure when adolescents had poor 
adherence to medicines, were engaging in risky behaviours, or when unaccompanied 
adolescents were asking the physicians why they were taking their medications or required 
to come to clinic.
The disclosure methods used by clinicians were varied. Some described encouraging 
caregivers to disclose to their child, while others described a more gradual process of 
educating the child about chronic disease and HIV generally and then progressing to tell the 
child they have HIV. One clinician noted:
“Health workers may use the methods that best work for them.”
Most were unable to provide specific details of their personal method of disclosing, and 
none identified a protocol to follow.
Accidental disclosure, or having an individual learn about their HIV status in an indirect or 
unintended way, appeared to be pervasive in the clinics. One clinician stated:
“Most of the disclosures in [my clinic], I would say are accidental.”
She went on to note that when children become 17–18 years old, the clinics assumed they 
already know their HIV status when, in fact, the adolescents may have never actually been 
informed. Other examples of how accidental disclosure occurred in clinics included when 
patients read their medical charts during a clinic visit or while participating in peer support 
groups. For example, two of the clinics created adolescent support groups to help support the 
many adolescents struggling with medication adherence, feelings of isolation, and limited 
knowledge of HIV care. These groups consisted of adolescents that were both disclosed and 
those who were not disclosed, which had the potential consequence of accidental disclosure.
Many barriers to adolescent disclosure were identified by participants, both for themselves 
as clinical providers and what they perceived for the caregivers. Two major themes in 
clinical provider barriers were clinic restraints (such as time limitations, patient volume, 
discontinuity with patients, and lack of designation of clinical staff responsible for 
disclosure) and lack of training in disclosure. Most clinical providers had no training specific 
to working with children and adolescents, and none expressed familiarity with the AMPATH 
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SOP for HIV disclosure. Participants perceived discomfort as the primary barrier to 
disclosure for caregivers in their clinics. This discomfort emanated from caregiver’s own 
lack of knowledge regarding HIV itself or how to disclose a child of their status, their fear of 
blame or the child’s reaction to learning their status, and the HIV-related stigma experienced 
within the communities where they live.
Implementation of Tablets:
After tablet initiation, monthly follow-up surveys indicated tablets were used during 75% or 
more of clinic encounters by 67% (14/21) of providers one month after tablet distribution 
and 85% (18/21) at the end of the study. The overall increase from one month to study 
completion was not statistically significant.
In the final survey, males indicated the tablet had been more helpful in impacting their HIV 
disclosure counselling than females (p=0.05). Also, in the final survey, there was a nearly 
statistically significant increase in the perceived enjoyment of using the tablet for 
counselling for males compared with females (p=0.06). No difference was seen among the 
clinical positions.
A significant improvement in comfort scores was seen between the first and third surveys 
(p=0.04), first and fourth surveys (p=0.02), and first and fifth surveys (p=0.03). In looking at 
clinic-specific differences, Clinic Site 2 had significantly lower comfort using the tablet for 
disclosure in the initial survey compared to Clinic Sites 1 and 3 (p<0.01). No other variables 
were found to be statistically significant. Summary statistics of the first and final monthly 
surveys’ data for comfort, ability, knowledge, impact of tablet, and patient’s reaction to the 
tablet are described in Table 2. Likert scores for all variables were skewed in an upwards 
direction with little variability in scores within and between variables.
Clinical Provider Follow-up Interviews
During five-month follow-up interviews with staff, all (n=21) providers reported tablets 
improved the clinic disclosure process by providing them access to resources to support their 
work. One participant noted:
“It has really changed disclosure as it has really helped the whole clinic and even 
the kids, in that there are so many materials here in the tablet we didn’t know, but 
through reading through it, it has really improved our skills.”
Resources most commonly utilized with patients were the narrative videos (used by n=21) 
and animation (used by n=19). The counselling guidelines were used by over half of the 
participants (n=12).
A few providers at each clinic described using the tablet computers in a group setting, but all 
reported using it one-on-one with adolescents and/or caregivers. Many (n=16) reported 
improved clinical participation and adherence and that the adolescents increasingly attended 
clinic specifically to watch tablet disclosure videos. One participant described this by noting:
“The children thought it was fun; they would come and then would want to see the 
tablet…it has helped them understand their status and what HIV is, so it brings a 
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lively discussion when we are discussing issues of HIV and adherence, because 
now children can relate HIV with something they have seen on the tablet.”
Clinical providers reported both caregivers and adolescents began initiating dialogue about 
critical issues such as medication adherence after watching the disclosure videos. One 
example of such dialogue was described by a provider:
“The caregivers didn’t keep the appointments for their children, and because we 
have been discussing this over and over and there is no change, so the day they 
landed, I just opened that [animation video]…and after seeing this, they were 
weeping. They were like, ‘I have been doing this to myself, I have been doing this 
to my child.’”
Additionally, all providers reported reviewing materials during their free time, typically 
outside of work, to increase their own knowledge and comfort with disclosure. One 
participant noted:
“[The tablet] assisted me to educate the clients, by opening my knowledge about 
how I should handle kids on disclosure…their challenges and some of the things 
that [adolescents] want to know. It helped me understand issues about disclosure to 
children which previously I didn’t really have the grasp of.”
Many of the providers (n=14) also reported discussing the information they learned from the 
tablet with other clinic providers not involved in the study. One provider described how she 
shared the tablet to have the resources viewed by more children:
“We have community health workers who are working with the children, so when 
they are going door-to-door in their work and they encounter issues in disclosure, I 
always discuss with them and tell them we have a tablet that can to assist them in 
disclosure, and they either come with the child or I guide them on how to use [the 
tablet], and then they bring it back the same day and so they have been doing that.”
Many participants (n=15) reported that issues they previously believed were barriers to 
disclosure for caregivers and providers were improved with the introduction of the tablets. 
However, time continued to be a barrier for use for some. Half of the participants (n=9) 
spent an average of 10–15 minutes using the tablet with each client, with most of the 
remaining participants using it for less time. The time spent in discussion of the materials 
seemed to be more of a barrier than the time spent viewing the resources. One participant 
noted:
“After they see the material on the tablet, they have a lot of questions to ask. It’s 
like you’ve popped them out their mind and they have a lot to ask about HIV and 
AIDS.”
Another identified barrier for use of the tablets included language of materials. One clinic 
had patients who neither spoke English nor Kiswahili, thus clinical providers had to actively 
translate resources into the local language for the patients, which was cumbersome and time-
consuming.
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Of note, one clinical provider also mentioned that accidental disclosure was a challenge in 
using the tablets. The participant noted:
“We have been playing these videos to these children, and we sometimes discover 
that they do not know they have HIV. Now they come [to know their status]. Now 
we wonder how they behave at home with the caregivers… In most cases, we do 
follow-up of cases where we felt that we have done accidental disclosure especially, 
we follow it up with caregivers. What was the behaviour? What did they experience 
after that? But so far, we have not had anything negative.”
No technical issues were reported, however some participants requested audio speakers and 
a projector to use the tablets with larger groups. In addition, despite the tablets having Wi-Fi 
capabilities, several participants requested internet access for the tablets to access additional 
materials and resources for their patients.
Suggestions for improvement included making more resources available on the tablet, such 
as additional narrative videos and animations on HIV-related topics, and additional 
information on puberty/sexuality and general HIV care.
One-Year Follow-Up
Clinical Provider Follow-Up Survey—Eighteen of the 21 initial clinical providers were 
available and willing to participate in a follow-up survey. Only 28% (5/18) continued to use 
the tablet during 75% or more of patient interactions, while 94% (17/18) used them in at 
least 25% of their interactions. The narrative videos and animation were still commonly 
utilized resources for patients (14/18 and 12/18 of participants utilizing them, respectively), 
while the number of providers using the counselling guidelines on disclosure of HIV was 
stable (n =13).
Most providers used the tablets with disclosed adolescents (n=16) or caregivers (n=16), 
while many (n=14) also used the tablet with adolescents who were in the disclosure process 
but did not yet know they had HIV. Few (n=6) used the tablet with pre-disclosed children. 
No episodes of accidental disclosure were reported.
All participants indicated that the tablets improved disclosure in their clinic, either by 
helping them become more knowledgeable and comfortable about the disclosure process, 
supporting caregivers to disclose to their adolescents, or helping adolescents understand the 
importance of medication adherence. A few providers also indicated that it helped the 
adolescents through the disclosure process as well.
Barriers to using the tablet remained similar to those noted previously: time and language. 
Technical issues were minimal. Two individuals also mentioned power was an issue because 
they would forget to charge it. One tablet was dropped, and the touch screen function no 
longer worked properly. None of the tablets were stolen or lost.
Most were satisfied with the tablet resources in their current form. Other suggestions for 
further improvement included adding new guidelines for HIV care on the tablets and 
organizing live disclosure training sessions for clinical providers at the clinics.
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Adolescent Perspectives—Three focus groups took place (one at each clinic), which 
involved 24 adolescents in total (Study Site 1 (n=12); Study Site 2 (n=7); and Study Site 3 
(n= 5)). The mean age of the adolescents was 13.8 years, ranging from 10–16 years, and the 
age at which they were disclosed ranged from 3–14 years, although the average age of 
disclosure was 10 years. Most adolescents had been disclosed to by a female family member 
(n=11 by mother, n=6 by grandmother, n=4 by aunt or sister). Two adolescents were 
disclosed to by their fathers and only one by a doctor.
Most adolescents had been exposed to the tablets during their clinic visits, and nearly all 
knew their status before being shown the videos. They described instances of using it one-
on-one with clinical providers, in a group with other adolescents, or both. Adolescents 
described only viewing the narrative videos and animation resources on the tablets. They 
self-reported that their medication adherence was the most significant factor that changed 
after viewing the videos. One adolescent noted:
“I was not taking my medicine on time but after watching the video am now taking 
my medicines on time and always.”
Another adolescent further described how these videos impacted him:
“We were shown [a video] about a boy who had been sick and not taking medicines 
and had no parents and had HIV. He then started taking medicine and never left the 
medicines, when I saw the video I believed. The doctor told me to go home and 
take the medicines. After three weeks I was tested and found my [CD4] level was 
high. The doctor told me now I knew the importance of taking medicines, and I told 
him now I know why I am taking medicines.”
The adolescents also described that the narrative videos helped them feel like they were not 
alone in their HIV diagnosis, which they described as an improvement of mood and mental 
health. One adolescent simply said:
“I did not like to be happy with others but after watching I can now laugh with 
others.”
Another adolescent added:
“I was referred to this hospital where I was supported and counselled on how to 
cope with the post disclosure effect. I don’t think of killing myself anymore but 
[rather] how to keep taking my pills well so that I can achieve my dream of being a 
productive person in life.”
All adolescents reported enjoying having the tablets as a resource in the clinics. They also all 
denied any challenges in using the tablets. When asked how to improve the usefulness of the 
tablets, they suggested that the tablets be used during every clinic visits, that clinicians 
should not be rushed when showing them the videos, and to include more videos addressing 
general adolescent stages.
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Discussion
We found that tablet computers containing HIV disclosure-related resources may be an 
acceptable and beneficial resource for clinical providers responsible for HIV disclosure with 
families at their clinics in western Kenya. The narrative videos and HIV animation were the 
most commonly used resources with patients. However, all clinicians reported reviewing the 
counselling training materials, AMPATH SOPs, and treatment guidelines on the tablets for 
self-education. Perceived challenges to using the tablets included time and language barriers. 
Although it was only noted by one clinical provider, there was still the possibility of 
accidental disclosure with tablet use if the tablets were not used appropriately. Both study 
participants and the adolescents expressed enjoyment in using the tablet computers during 
their clinic visits, particularly the multimedia videos and animation, and they appeared to be 
a helpful resource for disclosure counselling, as well as clinic and medication adherence 
counselling.
This study is the first to evaluate tablet computers for HIV disclosure counselling for 
adolescents and their caregivers in a RLS. This resource appeared to have the additional 
benefit of counselling on medication adherence, which was identified as an issue that 
influenced the clinical providers’ decision on when to initiate disclosure of an adolescent. 
This benefit is consistent with related studies from resource-rich settings. Tablet computers 
loaded with interactive health communication tools have been shown to be well received and 
easily usable by young adults for HIV and STD counselling (Mackenzie et al., 2007). 
Additionally, other means of utilizing portable electronic devices, such as daily text message 
reminders, have been found to improve HIV medication adherence in Kenya (Lester et al., 
2010). While this small study is significant in suggesting that tablet computers may be 
acceptable and helpful when counselling HIV-infected adolescents in RLS, more research is 
needed to see if this has benefits to patient outcomes on a larger scale.
A major feature and benefit of this study was the use of unique, culturally appropriate 
narrative videos and an animation about HIV, disclosure, and medication adherence created 
through extensive community engagement and contextual input (Fischer et al., 2015). These 
resources were preferred for use by participants over other pamphlets, guidelines, and 
workbooks available on the tablets. Adolescents found the videos and animation to be 
enjoyable and relatable to them in their own lives. These resources featured adolescents who 
were similar to them in age, interests (e.g. soccer/football, school work), and struggles. 
These commonalities may have contributed to their expression that they no longer felt alone. 
The peer groups in which these adolescents viewed the videos may also have worked 
synergistically with the tablet’s perceived benefits, by providing peer support from others 
faced with the same struggles and facilitating topics for their discussion. Digital-media has 
shown to have benefits in improving adolescent knowledge and behaviours on various 
topics, including sexual health and obesity (An, Hayman, Park, Dusaj, & Ayres, 2009; Guse 
et al., 2012). However, the majority of these studies are performed in resource-rich contexts 
and nearly all of them require continuous internet connectivity. Our study is innovative in 
that the tablets did not require internet access to fully access its resources. Further work is 
needed to develop additional resources that are accessible without continuous internet 
connectivity for use in RLS.
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Within the resources provided on these static tablets were guidelines and SOPs specifically 
for the clinical providers. By giving clinical providers resources to guide HIV-infected 
adolescents and their caregivers through the disclosure process, we hoped to empower them 
to expand their expertise and care of these patients. None of the clinical providers in this 
study reported any prior training in HIV disclosure. Although AMPATH SOPs exist 
regarding HIV disclosure and live trainings have been held on this topic, not all clinical 
providers have had access to these resources. The AMPATH SOPs are available online, but 
not all clinical staff have availability of the internet to view these materials during or outside 
of work hours. Paper copies may exist within the clinic setting, but these are easily lost and 
difficult to maintain. The providers’ reports suggest a similar situation to that reported in a 
study performed in Ethiopia, where they found that SOPs are not routinely followed even 
when they are available and their use is critical for good medical care (Weldu et al., 2017). 
While comprehensive HIV disclosure training would be ideal for all those working with 
HIV-infected adolescents and their caregivers, this may not be an option due to its high cost 
and Kenya’s high rate of clinical provider turnover. With tablet-based resources, providers 
are able to review materials outside of work hours, and it allows clinical systems the 
opportunity to easily and routinely update the content.
Accidental, or inadvertent, disclosure of an adolescent’s HIV status was a common theme 
that arose before the tablet intervention was introduced. While there is little literature 
describing the negative impacts that an accidental disclosure may have on a child, most 
guidelines recommend that the disclosure takes place over time as a process rather than a 
single, discrete event (Lesch et al., 2007; World Health Organization, 2011). Upon 
uncovering the apparent frequency at which accidental disclosure was occurring at the study 
sites, discussions about the importance of preventing accidental disclosures were included 
within the education the clinical providers received on the tablet computers. Additionally, 
the tablets had designated folders of resources to use based on the adolescent’s disclosure 
status. A process-oriented framework to help clinical providers and caregivers navigate the 
disclosure process was one of the resources available to clinical providers on the tablet (New 
York State Department of Health, 2009). However, despite these efforts, one of the clinical 
providers noted that accidental disclosure was still possible with use of the tablets. This was 
likely due to the limited number of videos that were appropriate for non-disclosed 
adolescents and the strongly expressed interest in watching the videos from the adolescents. 
If the clinical provider allowed them to watch the full range of videos available on the tablet 
computers, the adolescents would be exposed to videos designed specifically for those who 
know their HIV status. This was addressed with the providers during the interviews. At the 
one-year follow-up survey, there was no evidence that accidental disclosure was still an 
issue. Of note, based on the AMPATH SOP and the Kenya Ministry of Health guidelines, all 
children should have had disclosure initiated by the time they were 10 years of age, meaning 
that even an accidental disclosure would still be in line with the necessity of eventually 
disclosing the child’s status.
With the increasing interest in improving rates of disclosure for adolescents worldwide, it is 
critically important that all efforts should be made to adequately train staff on the issues 
related to accidental disclosure, design resources specific to non-disclosed children, and 
ensure that HIV disclosure takes place in a thoughtful, developmentally appropriate process. 
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Currently, there is no guidance on the ideal age for HIV disclosure. However, there is an 
emphasis on considering a child’s cognitive and developmental ability to understand what is 
being said before HIV disclosure (World Health Organization, 2011). In our pilot study, 
providers were instructed to choose materials based off of the disclosure status of the 
adolescent. Further guidance for clinical providers regarding the specific topics to be 
covered at each developmental stage is needed during HIV disclosure. Additionally, more 
resources need to be developed for children and adolescents who do not yet know their HIV-
status but are initiating the disclosure process. Future work should focus on addressing these 
issues.
When considering implementation of tablet computers for HIV disclosure counselling on a 
larger scale or for other educational purposes, a few factors should be considered. First, 
participants in this study reported that time limitations and patient volume were barriers to 
disclosure prior to tablet implementation that persisted or possibly worsened after 
implementation. Comprehensive assessment of clinic flow should be conducted prior to 
implementation of a new intervention to optimize its integration into current clinic activities 
without additional burdens. Clinics in this study found solutions by showing them in groups 
or on “adolescent days,” to reduce delays in clinic flow. However, any information provided 
in a group or public manner, such as media available in waiting areas, should be approached 
with caution to ensure that patients do not experience accidental disclosure or stigmatization.
Future work in this area should also consider language when developing and implementing 
electronic devices, such as tablet computers, for HIV disclosure in RLS. The resources on 
the tablet computers were in either Kiswahili or English, which are Kenya’s two official 
languages. However, in more rural areas of the country, tribal languages or “mother tongues” 
may be the only languages spoken. This is consistent with many other sub-Saharan African 
countries as well. Some health inequities these countries experience may be due in part to 
the lack of important health information provided in a local language and in a culturally 
sensitive manner (Mphasha & Lebese, 2015). These individuals are particularly vulnerable, 
and efforts should be made to ensure that they have equal access to beneficial health 
interventions.
Additional relevant and culturally appropriate resources should also be developed or adapted 
to engage adolescents on topics appropriate for their stage in HIV disclosure. Within the 
year-long study period, it was clear that many of the adolescents had exhausted the use of 
the materials and were requesting additional resources. While there are substantial benefits 
to utilizing electronic resources that do not require continuous internet connection, this does 
require a more concerted effort to systematically and routinely update the resources on the 
tablet. This could take place either manually or by supplying an internet connection and 
website where the materials could be downloaded. Regular updates could be supplemented 
with interrelated live trainings whenever possible. This type of regular contact using an 
accessible electronic platform allows for the dissemination of continuing clinical and 
medical education to clinical providers in RLS (Pakenham-Walsh & Bukachi, 2009; Rowe, 
de Savigny, Lanata, & Victora, 2005). However, it is critical that clinical providers are 
appropriately instructed on how to use these materials, such as avoiding accidental 
disclosure of HIV status, to ensure optimal care for patients.
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Using Likert scores to track changes in clinic comfort, knowledge, and skills on disclosure 
after implementation of the tablet computers proved to be a major challenge in our analysis. 
Although Likert scores have successfully been used in similar RLS, including Kenya 
(Finstad, 2010; Smit, van den Berg, Bekker, Seedat, & Stein, 2006), it was not found to be 
an effective means of evaluating the intervention in this study. When participants self-scored 
their own comfort, knowledge, and skills on disclosure using the Likert scales, they appeared 
to overestimate their answers compared to the description they provided of their experiences 
during the interviews. This is supported by the fact that the median scores were nearly all at 
the top of the Likert scale. This may have inaccurately represented their comfort, knowledge, 
and abilities. Social desirability bias is a known limitation for study designs utilizing certain 
types of self-reported questionnaires and surveys (Brener, Billy, & Grady, 2003; Harrison, 
1997). By having additional participant interviews, we were able to triangulate the 
information, showing that providers did perceive benefits from using the tablets for 
disclosure counselling.
Our results are limited by the small sample size of only a few clinics and participants, as 
well as the convenience sampling used to recruit participants. However, this is the nature of a 
pilot study, as we were limited by both time and the number of tablets available. With these 
results, we can now consider the possibility of scaling-up the program in the future. Another 
limitation to this study was that there were no patient outcome data collected. Within the 
pediatric medical records of the AMPATH clinics, a clinical question exists regarding the 
child’s disclosure status. However, on a data inquiry, it was found that less than half of the 
adolescents had data captured on that question. Thus, no analyses could be performed on 
that indicator. Future studies could consider prospectively collecting these data and tracking 
additional clinical outcomes, such as medication adherence and viral loads. Additionally, 
adolescent perspectives were limited in number, unequally distributed among clinics, and 
may not be representative of the experience of all adolescents exposed to the tablets. Also, 
no caregiver perspectives were included in this study. However, we do believe that the 
available data provided some key insights on the use of tablets within the clinics and the 
acceptability of the technology for use in HIV clinical care. Increase representation from 
both groups would be necessary in a full-scaled study.
Conclusions
Tablet computers with resources for disclosure are an acceptable resource for clinical 
providers who play a role in HIV disclosure for HIV-infected children and adolescents. They 
often used it to improve their own knowledge of HIV disclosure, and we found that their 
comfort in providing HIV disclosure counselling improved over time. Additionally, the 
adolescents viewed the tablet computers positively and reported improvements of 
medication adherence and mood resulting from this intervention. Distribution of resources 
for HIV disclosure should be accompanied with complete and targeted instructions on use, 
to ensure that specific resources are appropriately used for non-disclosed and disclosed 
adolescents, as well as their caregivers. Future studies should consider clinical outcomes 
related to tablet-based counselling resources and aim to gain more perspectives from 
adolescents and their caregivers.
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Table 1:
Clinical Provider Demographics
Table 1 reports the number and proportion of participants included in the study, by gender and clinic position. 
These results are also sub-divided into individual clinical sites
Variables:
Clinic Site
Total n (%) Study Site 1 n (%) Study Site 2 n (%) Study Site 3 n (%)
Gender:
 Males 8 (38.1) 3 (42.8) 3 (42.8) 2 (28.6)
 Females 13 (61.9) 4 (57.1) 4 (57.1) 5 (71.4)
Clinic Position:
 Clinical Officer 8 (38.1) 3 (42.8) 2 (28.6) 3 (42.8)
 Nurse 5 (23.8) 3 (42.8) 1 (14.3) 1 (14.3)
 Social Support 8 (38.1) 1 (14.3) 4 (57.1) 3 (42.8)
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Table 2:
Summary of Likert scores, first and last survey
Table 2 depicts the mean, median, and standard deviation (SD) of the survey results, measuring comfort, 
ability, knowledge, impact of table, and patient’s reaction, within the initial survey and the final survey. The 
survey used a 10-point Likert scale with 0 indicating the most negative or low score and 10 being the most 
positive or high score. The p-value was calculated using Wilcoxon Sum Rank, with α set at 0.05.
Variable Initial Survey Final Survey p-value
Mean, Median, SD Mean, Median, SD
Comfort 8.29, 8.00, 1.87 9.33, 10.00, 1.06 0.026
Ability 9.53, 10.00, 0.60 9.67, 10.00, 0.48 0.453
Knowledge 9.33, 10.00, 0.91 9.54, 10.00, 0.75 0.463
Impact of Tablet 9.52, 10.00, 0.98 9.71, 10.00, 0.56 0.516
Patient’s Reaction 9.10, 10.00, 1.37 9.62, 10.00, 0.50 0.090
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